This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Doi, L M Articles by Prata, J A Search for Related Content PubMed PubMed Citation Articles by Doi, L M Articles by Prata, J A, Jr

Effects of the combination of bimatoprost and latanoprost on intraocular pressure in primary open angle glaucoma: a randomised clinical trial

¹ Department of Ophthalmology, Federal University of São Paulo, São Paulo, Brazil
² Faculdade de Medicina do Triângulo Mineiro, Uberaba, Brazil

Correspondence to:
Correspondence to:
Luiz Alberto S Melo Jr
R Leandro Dupret 488/161, São Paulo, Brazil 04025-012; luizalberto{at}oftalmo.epm.br

ABSTRACT
Aims: To evaluate the effect of the combination of bimatoprost and latanoprost on intraocular pressure (IOP) in primary open angle glaucoma (POAG).

Methods: An open label randomised clinical trial was conducted, which included 18 glaucomatous patients (36 eyes). In the first 4 weeks, latanoprost 0.005% was prescribed for both eyes of the patients and any other antiglaucoma medication was discontinued. In the next 4 weeks (phase 1), bimatoprost 0.03% was combined with latanoprost in one randomly assigned eye (case eye) of each patient. In the next 4 weeks (phase 2), bimatoprost was discontinued in the case eyes, while bimatoprost was substituted for latanoprost in the fellow eye (control eye). The IOP was measured at the end of the first 4 weeks (baseline measurement) and weekly during phases 1 and 2.

Results: In the case eyes, the mean IOP increased along the first phase (1.8 mm Hg; p = 0.006) when compared to baseline measurements. The IOP returned to previous values after discontinuation of bimatoprost in phase 2. In the control eyes, the mean IOP did not change throughout the study.

Conclusion: The combination of bimatoprost and latanoprost in POAG increases the IOP and should not be considered as a therapeutic option.

Abbreviations: IOP, intraocular pressure; MD, mean deviation; POAG, primary open angle glaucoma

Keywords: primary open angle glaucoma; bimatoprost; latanoprost; intraocular pressure